Camber Pharmaceuticals launches spironolactone tablets, indicated for treatment of heart failure, hypertension, edema associated with hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. The tablets are available in 25 mg (100, 500, and 1000 count), 50 mg (100 and 150 count), and 100 mg (100 and 500 count).